Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

BACKGROUND: In order to improve the outcome of patients with non-small cell lung cancer (NSCLC), a biomarker that can predict the efficacy of chemotherapy is needed. The aim of this study was to assess the role of EGFR mutations and ERCC1 in predicting the efficacy of platinum-based chemotherapy and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yamashita, Fumie, Azuma, Koichi, Yoshida, Tsukasa, Yamada, Kazuhiko, Kawahara, Akihiko, Hattori, Satoshi, Takeoka, Hiroaki, Zaizen, Yoshiaki, Kawayama, Tomotaka, Kage, Masayoshi, Hoshino, Tomoaki
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734014/
https://ncbi.nlm.nih.gov/pubmed/23940741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0071356
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars